Shaping the medicine of tomorrow
Targeted therapy for complex conditions
Cannabinoid medicine represents a paradigm shift in the treatment of chronic conditions.
Rather than simply suppressing individual symptoms, this class of therapies targets the body’s own regulatory network: the endocannabinoid system (ECS).
By using high-quality phytocannabinoids—active compounds derived from the cannabis plant—the endocannabinoid system (ECS) can be modulated to support physiological balance (homeostasis).
At Galaxia, our goal is to support physicians and patients with reliable information and structured decision-making tools. These are designed to provide sound guidance for individual treatment decisions.
About Us
Galaxia Life is the specialized distribution arm of Galaxia Vertical, connecting the European pharmaceutical industry with high-quality medical cannabis. As a central link in the supply chain, we deliver fully traceable, high-quality medicinal products from our cultivation partners directly to pharmacies and patients who need them most.
We are committed to freedom of choice and safety, and we ensure that the consistency achieved during manufacturing is fully maintained throughout the distribution process. By presenting our unique product portfolio in an open and transparent manner, we lay the groundwork for healthcare providers and patients to make informed decisions.
We ensure that the Galaxia standard for quality, traceability, and sustainability is applied throughout the entire supply chain, all the way to the patient.
Our cultivators
Supply chain
Through GMP-certified production facilities, audited partners, and strict regulatory compliance, we work exclusively with growers, distributors, and logistics companies that we have vetted and regularly audit. This ensures end-to-end control of the supply chain—from cultivation to the pharmacy.
We operate globally and act locally—ensuring the Galaxia standard at every step of the value chain.
We supply the German market from Portugal, Switzerland, North Macedonia, and Canada—all based on a uniform quality standard.
Genetics
We collaborate with renowned breeding companies in North America and Europe and represent their genetic lines. At the same time, we make our own cultivars available to our long-standing cultivation partners. Our goal is to ensure a reliable supply and a diverse product selection for patients.
Research & Development
We have an in-house research and development program at our Portuguese facility that focuses on pharmaceutical innovations and the development of new products and dosage forms.